Eric Qiong Wu

Managing Principal

Expert

Eric Q. Wu

BeijingBoston

Education

Ph.D., pharmacoeconomics and policy, M.S., health care regulation and law, and M.A., economics, University of Southern California; B.S., Peking University

Summary of Experience

Dr. Wu is a health economist specializing in health economics, outcomes, and market access issues related to pharmaceuticals, biologics, and devices. He has broad experience consulting to pharmaceutical and device companies, payers, providers, and government agencies globally. Dr. Wu has extensive experience in health economics and outcomes research strategy development; analysis of medical claims and clinical trial data, patient chart review, patient surveys and physician surveys, and economic modeling to support treatment guideline development; global formulary and reimbursement submission; step therapy design; appropriate generics and biosimilars use; and investigations in comparative effectiveness, personalized medicine, direct and indirect resource utilization and costs, work loss, quality of life, treatment pattern, disease prevalence, and adverse events. His interests also include developing new methods and statistical tests to address challenges in health care research and application of medical big data. Dr. Wu sits on the advisory board of the Health Economic Evaluation Center of the Chinese Medical Doctor Association. He was a coeditor of PharmacoEconomics' special issue on health care in China.

中文版

Selected Publishing

  • The Economic Burden of Schizophrenia in the United States in 2013

    Journal of Clinical Psychiatry
    2016

    Wu EGuérin A, Cloutier M

      View abstract
    Health Care
  • Brentuximab Vedotin Compared with Other Therapies in Relapsed/Refractory Hodgkin Lymphoma Post ASCT: Median Overall Survival Meta-Analysis

    Curr Med Res Opin. 2015 May 7:1-48
    2015

    Bonthapally V, Yang H, Ayyagari R, Tan RD, Cai S, Wu E, Gautam A, Chi A, Huebner D

      View abstract
    Health Care
  • The epidemiology and targeted therapies for relapsed and refractory CD30+ lymphomas

    Curr Med Res Opin. 2015 Mar; 31(3):537-45
    2015

    Macalalad AR, McAuliffe M, Yang H, Kageleiry A, Zhong Y, Wu EQ, Shonukan O, Bonthapally V.

      View abstract
    Health Care
  • Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma post-autologous transplant: meta-analysis versus historical data

    Curr Med Res Opin. 2015 May; 31(5):993-1001
    2015

    Bonthapally V, Wu E, Macalalad A, Yang H, Shonukan O, Liu Y, Chi A, Huebner D.

      View abstract
    Health Care
  • Psoriasis and risk of diabetes-associated microvascular and macrovascular complications

    J Am Acad Dermatol. 2015 Jun;72(6):968-977.e2
    2015

    Armstrong AW, Guerin A, Sundaram M, Wu EQ, Faust ES, Ionescu-Ittu R, Mulani P 

      View abstract
    Health Care
  • Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases

    Fertil Steril. 2015 Jan; 103(1):163-71
    2015

    Fuldeore M, Yang H, Du EX, Soliman AM, Wu EQ, Winkel C.

      View abstract
    Health Care
  • Costs and Resource Utilization Associated With Anemia and Rash in Chronic Hepatitis C Patients Treated With Direct-Acting Antiviral Agents in the United States

    Clin Ther. 2015 Jun 22
    2015

    Le TK, Macaulay D, Kalsekar A, Yuan Y, Sorg RA, Wei J, Wu EQ

      View abstract
    Health Care
  • The economic burden of gastrointestinal stromal tumor (GIST) recurrence in patients who have received adjuvant imatinib therapy

    J Med Econ. 2015 Mar;18(3):241-8
    2015

    Guerin A, Sasane M, Gauthier G, Keir CH, Zhdavana M, Wu EQ

      View abstract
    Health Care
  • ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancer

    Cancer Epidemiol. 2015 Jun;39(3):307-12
    2015

    Guerin A, Sasane M, Zhang J, Macalalad AR, Galebach P, Jarvis J, Kageleiry A, Culver K, Wu EQ, Wakelee H 

      View abstract
    Health Care
  • Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevir

    J Manag Care Spec Pharm. 2015 Apr;21(4)
    2015

    Le TK, Kalsekar A, Macaulay D, Yuan Y, Sorg RA, Behrer CR, Wei J, Wu EQ

      View abstract
    Health Care
  • Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting

    Cancer Med. 2015 May 20. doi: 10.1002/cam4.475. [Epub ahead of print]
    2015

    Gibney GT, Gauthier G, Ayas C, Galebach P, Wu EQ, Abhyankar S, Reyes C, Guerin A, Yim YM

      View abstract
    Health Care
  • Nomenclature and traceability debate for biosimilars: small-molecule surrogates lend support for distinguishable nonproprietary names

    Adv Ther. 2015 Mar;32(3):270-83
    2015

    Chao J, Skup M, Alexander E, Tundia N, Macaulay D, Wu E, Mulani P

      View article
    Health Care
  • Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications

    J Med Econ. 2013 Nov;16(11):1275-89
    2015

    Setyawan J, Guerin A, Hodgkins P, Gauthier G, Cloutier M, Wu E, Erder MH

      View abstract
    Health Care
  • Distribution and drivers of costs in type 2 diabetes mellitus treated with oral hypoglycemic agents: a retrospective claims data analysis

    J Med Econ. 2014 Sep;17(9):646-57
    2014

    Bron M, Guerin A, Latremouille-Viau D, Ionescu-Ittu R, Viswanathan P, Lopez C, Wu EQ

      View abstract
    Health Care
  • Investigation of adverse-event-related costs for patients with metastatic breast cancer in a real-world setting

    Oncologist. 2014 Sep;19(9):901-8
    2014

    Hurvitz S, Guerin A, Brammer M, Guardino E, Zhou ZY, Latremouille Viau D, Wu EQ, Lalla D 

      View abstract
    Health Care
  • Budget impact analysis of liposomal amphotericin B and amphotericin B lipid complex in the treatment of invasive fungal infections in the United States

    Appl Health Econ Health Policy. 2014 Feb; 12(1):85-93
    2014

    Yang H, Chaudhari P, Zhou ZY, Wu EQ, Patel C, Horn DL.

      View abstract
    Health Care
  • Treatment patterns, prescribing decision drivers, and predictors of complete response following disease recurrence in gastrointestinal stromal tumor patients-a chart extract-based approach

    J Gastrointest Cancer. 2014 Dec;45(4):431-40
    2014

    Conley AP, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ

      View abstract
    Health Care
  • The impact of moderate-to-severe Crohn's Disease on employees' salary growth

    Inflamm Bowel Dis. 2014 Oct;20(10):1734-8
    2014

    Loftus EV Jr, Skup M, Ozbay AB, Wu E, Guerin A, Chao J, Mulani P 

      View abstract
    Health Care
  • Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension

    Curr Med Res Opin. 2014 Apr;30(4):637-43
    2014

    Chen S, Macaulay D, Swallow E, Diener M, Farooqui S, Xie J, Wu EQ

      View abstract
    Health Care
  • Risk of developing colorectal cancer and benign colorectal neoplasm in patients with chronic constipation

    Aliment Pharmacol Ther. 2014 Jul;40(1):83-92
    2014

    Guerin A, Mody R, Fok B, Lasch KL, Zhou Z, Wu EQ, Zhou W, Talley NJ

      View abstract
    Health Care
  • Economic benefits of adequate molecular monitoring in patients with chronic myelogenous leukemia

    J Med Econ. 2014 Feb;17(2):89-98
    2014

    Guerin A, Chen L, Dea K, Wu EQ, Goldberg SL

      View abstract
    Health Care
  • Impact of low-grade adverse events on health-related quality of life in adult patients receiving imatinib or nilotinib for newly diagnosed Philadelphia chromosome positive chronic myelogenous leukemia

    Curr Med Res Opin. 2014 Nov;30(11):2317-28
    2014

    Guerin A, Chen L, Ionescu-Ittu R, Marynchenko M, Nitulescu R, Hiscock R, Keir C, Wu EQ

      View abstract
    Health Care
  • Comparison of treatment patterns and economic outcomes in metastatic breast cancer patients initiated on trastuzumab versus lapatinib: a retrospective analysis

    Springerplus. 2014 May 8;3:236
    2014

    Guerin A, Lalla D, Gauthier G, Styles A, Wu EQ, Masaquel A, Brammer MG

      View abstract
    Health Care
  • Association between regular molecular monitoring and tyrosine kinase inhibitor therapy adherence in chronic myelogenous leukemia in the chronic phase

    Curr Med Res Opin. 2014 Jul;30(7):1345-52
    2014

    Guerin A, Chen L, Dea K, Wu EQ, Goldberg SL

      View abstract
    Health Care
  • Comparison of survival and hospitalization rates between Medicare patients with advanced NSCLC treated with bevacizumab-carboplatin-paclitaxel and carboplatin-paclitaxel: a retrospective cohort study

    Lung Cancer. 2014 Dec;86(3):350-7
    2014

    Langer C, Ravelo A, Hazard SJ, Guerin A, Ionescu-Ittu R, Latremouille-Viau D, Wu EQ, Ramalingam S

      View abstract
    Health Care
  • Development and validation of a claims-based prediction model for COPD severity

    Respiratory Medicine, June 2013
    2013

    Macaulay D, Sun SX, Sorg RA, Yan SY, De G, Wu EQ, Simonelli PF

      View abstract
    Health Care
  • Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States

    J Med Econ. 2013; 16(2):278-88
    2013

    Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M.

      View abstract
    Health Care
  • Comparison of the long-term risk of recurrence and other clinical outcomes in GIST patients receiving imatinib as adjuvant therapy--a retrospective chart extract-based approach

    J Gastrointest Cancer. 2013 Jun;44(2):190-8
    2013

    Conley AP, Guerin A, Sasane M, Gauthier G, Schwiep F, Keir CH, Wu EQ

      View abstract
    Health Care
  • A longitudinal analysis of costs associated with change in disease activity in systemic lupus erythematosus

    J Med Econ. 2013;16(6):793-800
    2013

    Kan H, Guerin A, Kaminsky MS, Yu AP, Wu EQ, Denio A, Priti J, Narayanan S, Molta C

      View abstract
    Health Care
  • Association between molecular monitoring and long-term outcomes in chronic myelogenous leukemia patients treated with first line imatinib

    Curr Med Res Opin. 2013 Sep;29(9):1075-82
    2013

    Goldberg SL, Chen L, Guerin A, Macalalad AR, Liu N, Kaminsky M, Ericson SG, Wu EQ

      View abstract
    Health Care
  • Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adults

    J Med Econ. 2013 Oct;16(10):1203-15
    2013

    Setyawan J, Hodgkins P, Guerin A, Gauthier G, Cloutier M, Wu E, Erder MH

      View abstract
    Health Care
  • Outcomes in atrial fibrillation patients on combined warfarin & antiarrhythmic therapy

    Int J Cardiol. 2013 Jul 31;167(2):564-9
    2013

    Guerin A, Lin J, Jhaveri M, Wu EQ, Yu AP, Cloutier M, Gauthier G, Alpert JS

      View abstract
    Health Care
  • Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis

    J Med Econ. 2013 Jul;16(7):962-75
    2013

    Setyawan J, Hodgkins P, Guerin A, Gauthier G, Cloutier M, Wu EQ, Erder MH 

      View abstract
    Health Care
  • Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy

    2012 Nov;19(6):e157-66
    2012

    Wu EQ, Forsythe A, Guerin A, Yu AP, Latremouille-Viau D, Tsaneva M

      View abstract
    Health Care
  • Reduced mortality in cystic fibrosis patients treated with tobramycin inhalation solution

    Pediatr Pulmonol. 2012 Jan;47(1):44-52. doi: 10.1002/ppul.21521. Epub 2011 Aug 3.
    2012

    Sawicki G, Signorovitch J, Zhang J, Latremouille-Viau D, von Wartburg M, Wu EQ, Shi L

      View abstract
    Health Care
  • Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer in the United States

    Journal of Medical Economics, 1-26, November 16, 2012
    2012

    Xie J, Diener M, De G, Yang H, Wu EQ, Namjoshi M

      View abstract
    Health CareIntellectual PropertyStrategy, Policy & Analytics
  • Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers

    Journal of Medical Economics, 1-30, November 27, 2012
    2012

    Ray S, Bonthapally V, Holen K, Gauthier G, Wu EQ, Cloutier M, Guérin A

      View abstract
    Health Care
  • Identifying patient subgroups who benefit most from a treatment: using administrative claims data to uncover treatment heterogeneity

    J Med Econ. 2012; 15(6):1078-87
    2012

    Erder MH, Signorovitch JE, Setyawan J, Yang H, Parikh K, Betts KA, Xie J, Hodgkins P, Wu EQ.

      View abstract
    Health Care
  • Treatment patterns and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients

    J Med Econ. 2012; 15(4):786-95
    2012

    Kim Le T, Winfree KB, Yang H, Marynchenko M, Yu AP, Frois C, Wu EQ.

      View abstract
    Health Care
  • A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care

    Pediatr Pulmonol. 2013 Oct;48(10):954-61
    2012

    Sawicki GS, Ayyagari R, Zhang J, Signorovitch JE, Fan L, Swallow E, Latremouille-Viau D, Wu EQ, Shi L

      View abstract
    Health Care
  • Risks of developing psychiatric disorders in pediatric patients with psoriasis

    J Am Acad Dermatol. 2012 Jan 11.
    2012

    Kimball A, Wu EQ, Guérin A, Yu AP, Tsaneva M, Gupta S, Bao Y, Mulani P

      View abstract
    Health Care
  • Re: Stopeck A, Rader M, Henry D, et al. Cost-effectiveness of denosumab vs. zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

    Journal of Medical Economics; December 5, 2012 [Letter to the Editor]
    2012

    Xie J, Diener M, Sorg R, Wu EQ, Namjoshi M

      View abstract
    Health Care
  • Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs

    Diabetes, Obesity and Metabolism, November 2012
    2012

    Signorovitch J, Macaulay D, Diener M, Yan Y, Wu EQ, Gruenberger J, Frier B

      View abstract
    Health Care
  • Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents

    Pharmacoeconomics. 2012 Aug 1;30(8):e1-15
    2012

    Sikirica V, Haim Erder M, Xie J, Macaulay D, Diener M, Hodgkins P, Wu EQ

      View abstract
    Health CareStrategy, Policy & Analytics
  • Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs

    Postgrad Med. 2012 Jan; 124(1):124-32
    2012

    Bron M, Marynchenko M, Yang H, Yu AP, Wu EQ

      View abstract
    Health Care
  • Copayment level, treatment persistence, and health care utilization in hypertension patients treated with single-pill combination therapy

    J Med Econ. 2011 Mar 30.
    2011

    Yang W, Kahler KH, Fellers T, Orloff J, Chang J, Bensimon AG, Wu EQ, Fan CP, Yu AP

      View abstract
    Health Care
  • Efficacy and safety of adalimumab among patients with moderate to severe psoriasis with co-morbidities

    Am J Clin Dermatol. 2011 Feb 1;12(1):51-62
    2011

    Kimball A, Bensimon A, Guerin A, Yu AP, Wu EQ, Okun M, Bao Y, Gupta S, Mulani P

      View abstract
    Health Care
  • Compliance, persistence, healthcare resource use, and treatment costs associated with aliskiren plus ARB versus ACE inhibitor plus ARB combination therapy

    Am J Cardiovasc Drugs. 2011;11(1):21-32
    2011

    Chang J, Yang W, Kahler KH, Fellers T, Orloff J, Bensimon AG, Yu AP, Fan CP, Wu EQ

      View abstract
    Health Care
  • Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus

    Curr Med Res Opin. 2011 Jan; 27(1):189-95. Epub 9 Dec, 2010
    2011

    Pandya B, Bron M, McCall T, Yu AP, Chen K, Mattson M, Wu EQ

      View abstract
    Health Care
  • Economic burden of comorbidities in patients with psoriasis is substantial

    J Eur Acad Dermatol Venereol. 2011 Feb; 25(2):157-63. Epub 2010 Jun 17.
    2011

    Kimball A, Guerin A, Tsaneva M, Yu AP, Wu EQ, Gupta S, Bao Y, Mulani P

      View abstract
    Health Care
  • Economic impact of therapeutic substitution of a brand selective serotonin reuptake inhibitor with an alternative generic selective serotonin reuptake inhibitor

    Ann Pharmacother. 2011 Mar 17.
    2011

    Wu EQ, Yu AP, Lauzon V, Ramakrishnan K, Marynchenko M, Ben-Hamadi R, Blum S, Erder M

      View abstract
    Health Care
  • Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes: a matching-adjusted indirect comparison of randomized trials

    Clin Drug Investig. 2011;31(9):665-74. doi: 10.2165/11592490-000000000-00000.
    2011

    Signorovitch J, Wu EQ, Swallow E, Kantor E, Fan L, Gruenberger J

      View abstract
    Health Care
  • Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors

    Curr Med Res Opin. 2011 Jun;27(6):1089-96. Epub 2011 Mar 28. Erratum in: Curr Med Res Opin. 2011 Sep;27(9):1708.
    2011

    Signorovitch J, Ramakrishnan K, Ben-Hamadi R, Yu AP, Wu EQ, Dworak H, Erder M

      View abstract
    Health Care
  • Economic Outcomes of Switching Treatment in Major Depressive Disorder Patients

    Am J Pharm Benefi ts. 2011;3(6):e111-e120
    2011

    Marynchenko M, Yu AP, Lauzon V, Ramakrishnan K, Wu EQ, Ben-Hamadi R, Blum S, Erder M, Bose A

      View article
    Health Care
  • The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of US Veterans

    Prostate Cancer Prostatic Dis. 2011 Mar;14(1):79-84. Epub 2010 Dec 21
    2011

    Velde N, Wu EQ, Guo A, Lu M, Yu AP, Sharma H, Liu J, Fan C, Shi L

      View abstract
    Health Care
  • Risk-benefit analysis of adalimumab versus traditional non-biologic therapies for patients with Crohn's disease

    Inflammatory Bowel Diseases. 2011, 17(1), 127-140
    2011

    Loftus E Jr, Johnson S, Wang S, Wu EQ, Mulani PM, Chao J

      View abstract
    Health Care
  • Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials

    Curr Med Res Opin. 2011 Jun;27(6):1263-71. Epub 2011 Apr 28
    2011

    Signorovitch J, Wu EQ, Betts K, Parikh K, Kantor E, Guo A, Bollu V, Williams D, Wei L, DeAngelo D

      View abstract
    Health Care
  • Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases

    Journal of Managed Care Pharmacy. 2011;17(8):621-34
    2011

    Xie J, Namjoshi M, Wu EQ, Parikh K, Diener M, Yu AP, Guo A, Culver KW

      View article
    Health Care
  • Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD

    J Med Econ. 2011;14(6):805-15. Epub 2011 Oct 12.
    2011

    Sun S, Marynchenko M, Banerjee R, Cheng D, Mocarski M, Yin D, Yu AP, Wu EQ

      View abstract
    Health Care
  • Increased risks of developing anxiety and depression in young patients with Crohn's disease

    Am J Gastroenterol. 2011 Sep;106(9):1670-7. doi: 10.1038/ajg.2011.142. Epub 2011 May 3.
    2011

    Loftus E Jr, Guerin A, Yu AP, Wu EQ, Yang M, Chao J, Mulani P

      View abstract
    Health Care
  • Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD

    Respir Med. 2011 Dec;105(12):1861-71. Epub 2011 Jul 31.
    2011

    Yu AP, Guerin A, de Leon DP, Ramakrishnan K, Wu EQ, Mocarski M, Blum S, Setyawan J

      View abstract
    Health Care
  • Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer

    J Med Econ. 2011; 14(5):542-52
    2011

    Yang H, Yu AP, Wu EQ, Yim YM, Yu E.

      View abstract
    Health Care
  • Therapy persistence and adherence in patients with chronic obstructive pulmonary disease: multiple versus single long-acting maintenance inhalers

    J Med Econ. 2011;14(4):486-96. Epub 2011 Jun 16.
    2011

    Yu AP, Guerin A, Ponce de Leon D, Ramakrishnan K, Wu EQ, Mocarski M, Blum S, Setyawan J

      View abstract
    Health Care
  • Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis

    J Med Econ. 2011; 14(3):315-23
    2011

    Yu AP, Yang H, Wu EQ, Setyawan J, Mocarski M, Blum S.

      View abstract
    Health Care
  • Comparison of skeletal complications and treatment patterns associated with early vs. delayed zoledronic acid therapy in multiple myeloma

    Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):326-35. Epub 2011 May 6
    2011

    Wu EQ, Bensimon A, Marynchenko M, Namjoshi M, Guo A, Yu AP, Ericson S, Raje N

      View abstract
    Health Care
  • The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial

    J Am Acad Dermatol. 2010 May;62(5):812-8. Epub 2010 Mar 9
    2010

    Menter A, Augustin M,  Signorovitch J, Yu A,  Wu E, Gupta S, Bao Y, Mulani P

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients

    Current Medical Research and Opinion. 2010 Jan;26(1):61-9
    2010

    Wu E, Johnson S, Beaulieu N, Arana M, Bollu V, Guo A, Coombs J, Feng W, Cortes J

      View abstract
    Health Care
  • High prevalence of potential drug-drug interactions for psoriasis patients prescribed methotrexate or cyclosporine for psoriasis

    Dermatology. 2010;220(2):128-37. Epub 2010 Feb 3
    2010

    Saurat J,  Guerin A, Yu A, Latremouille-Viau D,  Wu E, Gupta S, Bao Y, Mulani P

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: a retrospective database analysis

    Diabetes Res Clin Pract. 2010 Jan;87(1):108-16
    2010

    Lee L, Yu A, Johnson S,  Birnbaum H, Atanasov P, Buesching D, Jackson J, Davidson J

      View abstract
    Health Care
  • Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials

    Dermatology. 2010;220(1):1-7. Epub 2009 Nov 19
    2010

    Mease P,  Signorovitch J, Yu A,  Wu E, Gupta S, Bao Y, Mulani P

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment

    Pharmacoeconomics. 2010 Oct 1;28(10):935-45. doi: 10.2165/11538370-000000000-00000
    2010

    Signorovitch JWu E, Yu A, Gerrits C, Kantor E, Bao Y, Gupta S, Mulani P

      View abstract
    Health Care
  • Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives

    Curr Med Res Opin. 2010 Sep;26(9):2065-76
    2010

    Yang W, Chang J, Kahler K, Fellers T, Orloff J, Wu E, Bensimon A

      View abstract
    Health Care
  • The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients w Crohn's

    Aliment Pharmacol Ther. 2010 Nov; 32(10):1228-39
    2010

    Lichtiger S, Binion D, Wolf D, Present D, BensimonA, Wu EQ, Yu AP, Cardoso A, Chao J, Mulani P, Lomax K, Kent J

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Benefit-risk analysis of adalimumab vs methotrexate and placebo in the treatment of moderate to severe psoriasis

    J Am Acad Dermatol. 2010 Oct 6. [Epub ahead of print]
    2010

    Reich K,  Signorovitch J, Ramakrishnan K, Yu A, Wu EQ, Gupta S, Bao Y, Mulani P

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Economic consequence of switching to citalopram after its generic entry for adult patients with major depressive disorder (MDD) treated with escitalopram

    J Med Econ. 2010 Sep 29. [Epub ahead of print]
    2010

    Yu A,  Xie J, Bensimon A, Parikh K,  Wu E, Ben-Hamadi R, Blum S, Haim Erder

      View abstract
    Health Care
  • Systematic review: the costs of ulcerative colitis in Western countries

    Aliment Pharmacol Ther. 2010 Apr;31(7):693-707
    2010

    Cohen R, Yu AP,  Wu EQXie J, Mulani P, Chao J

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Retrospective real-world comparison of medical visits, costs, and adherence between nilotinib and dasatinib in chronic myeloid leukemia

    Current Medical and Research Opinion, December 2010, Vol. 26, No. 12 , Pages 2861-2869
    2010

    Wu EQGuerin A, Yu A, Bollu V, Guo A, Griffin J

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement

    Curr Med Res Opin. 2010 Sep;26(9):2203-12
    2010

    Chang J, Yang W, Fellers T, Kahler K, Orloff J,  Xie J, Tsaneva M, Yu A,  Wu EQ

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Healthcare utilization and costs incurred by patients with major depression after being switched from escitalopram to another SSRI for non-medical reasons

    J Med Econ. 2010;13(2):314-323
    2010

    Wu E, Ben-Hamadi R, Yu A, Tang J, Haim Erder M, Bose A

      View abstract
    Health Care
  • Economic impact of switching from valsartan to other angiotensin receptor blockers in patients with hypertension

    Curr Med Res Opin. 2010 Apr; 26(4):849-60
    2010

    Signorovitch J, Zhang J, Wu EQ, Latremouille-Viau D, Yu AP, Dastani HB, Kahler KH

      View abstract
    Health Care
  • Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

    Am J Gastroenterol. 2009 May;104(5):1170-9
    2009

    Colombel JF, Sandborn WJ, Rutgeerts P, Kamm MA, Yu AP,  Wu EQ, Pollack PF, Lomax KG, Chao J, Mulani PM

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Economic burden of psoriasis compared to the general population and stratified by disease severity

    Curr Med Res Opin. 2009 Oct;25(10):2429-38
    2009

    Yu AP, Tang J,  Xie JWu EQ, Gupta SR, Bao Y, Mulani PM

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone-budesonide and formoterol-salmeterol

    Clin Ther. 2009 Dec;31(12):2779-803
    2009

    Frois CWu E, Ray S, Colice G

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease

    Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1302-9
    2009

    Loftus E Jr, Johnson S, Yu A, Wu E, Chao J, Mulani P

      View abstract
    Health Care
  • Cost utility of adalimumab versus infliximab maintenance therapies in the United States for moderately to severely active Crohn's disease

    Pharmacoeconomics. 2009;27(7):609-21
    2009

    Yu AP, Johnson S, Wang ST, Atanasov P, Tang J, Wu E, Chao J, Mulani PM

      View abstract
    Health Care
  • Treatment persistence, healthcare utilisation and costs in adult patients with major depressive disorder: a comparison between escitalopram and other SSRI/SNRIs

    J Med Econ. 2009 Jun;12(2):124-35. doi: 10.3111/13696990903093537.
    2009

    Wu EQ, Greenberg PE, Yang E, Yu AP, Ben-Hamadi R, Erder MH.

      View abstract
    Health Care
  • Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study

    Gastroenterology. 2008 Aug 3.
    2008

    Feagan B, Panaccione R, Sandborn W, D'Haens G, Schreiber S, Rutgeerts P, Loftus EV J, Lomax K, Yu AP,  Wu EQ
    Chao J, Mulani P

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Comparison of treatment persistence, hospital utilization, costs among major depressive disorder geriatric patients treated with escitalopram

    Current Medical Research and Opinion 2008;24(10):2805-13
    2008

    Wu E, Greenberg P, Yang E, Yu A, Ben-Hamadi R, Erder M

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Loss of Treatment Response to Infliximab Maintenance Therapy in Crohn's Disease: A Payor Perspective

    Value Health, May 16, 2008
    2008

    Wu E, Mulani P, Yu A, Tang J, Pollack PF

      View abstract
    Health Care
  • Disease-related and all-cause health care costs of elderly patients with gout

    J Manag Care Pharm 2008 Mar;14(2):164-75
    2008

    Wu E, Patel P, Yu A, Mody R, Cahill K, Tang J, Krishnan E

      View abstract
    Health Care
  • Retrospective claims data analysis of dosage adjustment patterns of TNF antagonists among patients with rheumatoid arthritis.

    Curr Med Res Opin 2008 Aug;24(8):2229-40.
    2008

    Wu E, Chen L, Birnbaum H, Yang E, Cifaldi M

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Comparison of escitalopram versus citalopram for the treatment of major depressive disorder in a geriatric population

    Current Medical Research and Opinion 2008;24(9):2587-2595
    2008

    Wu E, Greenberg P, Yang E, Yu A, Erder M

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Estimated prevalence of peripheral neuropathy and associated pain in adults with diabetes in France

    Current Medical Research and Opinion; Sep;23(9):2035-42
    2007

    Wu E, Borton J, Said G, T.K. Le, Monz B, Rosilio M, Avoinet S

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents

    Current Medical Research and Opinion; Sep;23(9):2157-69
    2007

    Yu A, Wu E, Birnbaum H, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Retrospective Economic and Outcomes Analysis Using International Databases: A Review

    PharmacoEconomics; 25(7):563-76
    2007

    Shi L, Wu E, Hodges M, Yu A, Birnbaum H

    Epidemiology & BiostatisticsHealth Care
  • Mapping FACT-P and EORTC QLQ-C30 to the EQ-5D Health Utility in Metastatic Hormone-Refractory Prostate Cancer Patients

    Value Health; Sep-Oct;10(5):408-14
    2007

    Wu E, Mulani P, Farrell, Sleep D

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China

    Gynecologic Oncology; 2007 Jan;104(1):77-85. Epub 2006 Sep 12.
    2007

    Qiu A, Wu E, Yu X, Jiang C, Jin Y, Wu Y, Chen Y, Chen Y, Shan Y, Zhang G, Fan Y, Zha X, Kong W

    Epidemiology & BiostatisticsHealth Care
  • Retrospective economic and outcomes analyses using non-US databases: a review

    Pharmacoeconomics 2007;25(7):563-76
    2007

    Shi L, Wu E, Hodges M, Yu A, Birnbaum H

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Cost of care for patients with rheumatoid arthritis receiving TNF-antagonist therapy using claims data

    Curr Med Res Opin 2007 Aug;23(8):1749-59
    2007

    Wu E, Chen L, Birnbaum H, Yang E, Cifaldi M

      View abstract
    Health Care
  • Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patients

    Cancer 2007 Mar;109(6):1090-6
    2007

    Wu E, Mulani P, Farrell M, Sleep D

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Impact of cardiometabolic risk factor clusters on health-related quality of life in the US

    Obesity; Feb;15(2):511-21
    2007

    Sullivan P, Ghushchyan V, Wyatt H, Wu E, Hill J

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Use of Inhaled Corticosteroids and Healthcare Costs in Mild Persistent Asthma

    Journal of ASTHMA; Jul-Aug;44(6):479-83
    2007

    Colice G, Wu E, Birnbaum H, Daher M, Marynchenko M

      View abstract
    Health Care
  • Productivity costs associated with cardiometabolic risk factor clusters in the United States

    Value Health 2007 Nov-Dec;10(6):443-50
    2007

    Sullivan P, Ghushchyan V, Wyatt H, Wu E, Hill J

      View abstract
    Health Care
  • Impact of Single-Photon Emission Computed Tomography (SPECT) Use After Acute Myocardial Infarction (AMI) on Cardiac Procedure Rates and Hospital Length of Stay

    J Nucl Cardiol 2007;14(4):S115
    2007

    Wu E, Persson B, Beaulieu N, White L, Spalding J, Mahmarian J

    Epidemiology & BiostatisticsHealth Care
  • Health Care and Workloss Costs Associated with Persistent Asthma Patients in a Privately Insured Population

    Journal of Occupational and Environmental Medicine, 2006 Aug;48(8):794-802
    2006

    Colice G, Wu EBirnbaum H, Daher M, Marynchenko M, Faruqi R, Varghese S

      View abstract
    Health CareInsuranceStatistics & Sampling
  • Annual costs associated with diagnosis of uterine leiomyomata

    Obstet Gynecol 2006 Oct;108(4):930-7
    2006

    Hartmann K, Birnbaum H, Ben-Hamadi R, Wu E, Farrell M, Spalding J, Stang P

      View abstract
    Health Care
  • Cost-Effectiveness of Duloxetine versus Routine Treatment for U.S. Patients With Diabetic Peripheral Neuropathic Pain

    J Pain 2006 Jun;7(6):399-407
    2006

    Wu E, Birnbaum H, Mareva M, Kim Le T, Robinson R, Rosen A, Gelwicks S

      View abstract
    Health Care
  • Annual Prevalence of Diagnosed Schizophrenia in the United States: A Claims Data Analysis Approach

    Psychol Med. 2006 Nov;36(11):1535-40. Epub 2006 Aug 15.
    2006

    Wu EQ, Shi L, Birnbaum H, Hudson T, Kessler R

      View abstract
    Health Care
  • Development of a COPD Severity Score

    Curr Med Res Opin 2006;22(9):1679-87
    2006

    Wu E, Birnbaum H, Cifaldi M, Kang Y, Mallet D, Colice G

      View abstract
    Health Care
  • A Retrospective Claims Database Analysis to Assess Patterns of Interstitial Cystitis (IC) Diagnosis

    Curr Med Res Opin 2006 March;22(3):495-500
    2006

    Wu E, Birnbaum H, Kang Y, Parece A, Mallett D, Taitel H, Evans R

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Lifetime Costs of Patients with Clinically-Detected Uterine Fibroids: An Employer's Perspective

    Drug Benefit Trends, 2006, 18(7): 405-10
    2006

    Wu E, Ben-Hamadi R,  Birnbaum H, Farrell M, Spalding J, Stang P, Hartmann K

    Health Care
  • Healthcare and workloss costs associated with patients with persistent asthma in a privately insured population

    J Occup Environ Med 2006 Aug;48(8):794-802
    2006

    Colice G, Wu E, Birnbaum H, Daher M, Marynchenko M, Varghese S

      View abstract
    Health Care
  • Impact of stroke on health-related quality of life in the noninstitutionalized population in the United States

    Stroke, 2006 Oct;37(10):2567-72
    2006

    Xie J, Wu E, Zheng Z, Croft J, Greenlund K, Mensah G, Labarthe D

      View abstract
    Epidemiology & BiostatisticsHealth Care
  • Interstitial Cystitis: Cost, Treatment and Co-morbidities in an Employed Population

    Pharmacoeconomics 2006;24(1):55-65
    2006

    Wu E, Birnbaum H, Mareva M, Parece A, Huang Z, Mallett D, Taitel H

      View abstract
    Health Care
  • Economic burden and co-morbidities of atrial fibrillation in a privately insured population

    Curr Med Res Opin. 2005 Oct;21(10):1693-9.
    2005

    Wu EQ, Birnbaum HG, Mareva M, Tuttle E, Castor AR, Jackman W, Ruskin J.

      View abstract
    Health CareInsurance
  • Employees With Overactive Bladder: Work Loss Burden

    J Occup Environ Med. 2005 May;47(5):439-46.
    2005

    Wu EQ, Birnbaum H, Marynchenko M, Mareva M, Williamson T, Mallett D

      View abstract
    Health Care
  • The prevalence and correlates of nonaffective psychosis in the National Comorbidity Survey Replication (NCS-R)

    Biol Psychiatry. 2005 Oct 15;58(8):668-76. Epub 2005 Jul 14
    2005

    Kessler RC, Birnbaum H, Demler O, Falloon IR, Gagnon E, Guyer M, Howes MJ, Kendler KS, Shi L, Walters E, Wu EQ

      View abstract
    Health Care
  • The Economic Burden of Schizophrenia in the United States in 2002

    J Clin Psychiatry 2005. Sep;66(9):1122-9
    2005

    Wu E, Birnbaum HG, Shi L, Ball DE, Kessler RC, Moulis M, Aggarwal J.

      View abstract
    Health Care
  • China's urban health insurance reform experiment in Zhenjiang: cost and utilization analyses

    The Economics of Health Care in Asia-Pacific Countries, Edward Elgar Publishing Limited
    2002

    Liu G, Cai R, Chao S, Xiong X, Zhao Z, Wu E

    Health Care